Injective $INJ posts a notable intraday rise amid weakening fundamentals - bearish momentum remains dominant.

Market Condition
$INJ is trading in a cautious and sentiment-pressured environment, with analysts highlighting deteriorating fundamentals and challenging market sentiment.
Despite active participation, the broader trend remains bearish, with near-term downside risks outweighing short-term gains.

Recent Token Movement
On Dec 08, 2025 06:00, $INJ recorded a 4.04% increase, rising from $5.54 to $5.64.
24h trading volume reached $69.3M $INJ, reflecting active but cautious market activity.
The intraday gain represents short-term buying but does not indicate a reversal of the prevailing bearish trend.

Token Price Overview
Current Price: $5.64
24h Range: $5.54 – $5.64
24h Volume: $69.3M INJ
Context: Active trading with orderly movement; sentiment remains negative.

Market Dynamics
$INJ is trading near key technical levels while momentum indicators show a temporary lift:
Support Zone: ~$5.50
Resistance Zone: ~$5.68 – $5.72
Momentum reflects a short-term intraday lift, but the broader trend continues downward.
Analysts caution that the recent price increase is reactive and does not alter the bearish structure.

Sentiment Overview
Overall sentiment remains negative, driven by weakening fundamentals.
Retail flows are moderate but cautious.
Institutional participation remains defensive, limiting upward pressure.

Key Levels & Technical Signals
Support: ~$5.50
Resistance: ~$5.68 – $5.72
Momentum: Mild intraday lift within a larger bearish trend.

Volume Profile: Active, reflecting short-term buying amid broader caution.
Trading Insights
Expect moderate volatility with limited upside potential.
A move above $5.72 could offer temporary relief, while sustained trading near support may reinforce downside pressure.

Expert Summary
Despite a noticeable intraday rise, analysts maintain a bearish outlook on $INJ due to deteriorating fundamentals and challenging sentiment, which continue to dominate near-term price behavior.

Conclusion:
Based on expert evaluations, $INJ is a Sell candidate, with downside risks outweighing short-term gains.

@EdgenTech